-
1
-
-
0037309268
-
The neurobiology, diagnosis, and treatment of narcolepsy
-
Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol. 53:2003;154-166
-
(2003)
Ann Neurol
, vol.53
, pp. 154-166
-
-
Scammell, T.E.1
-
2
-
-
0344444257
-
Hypocretins/orexins and narcolepsy: From molecules to disease
-
Peyron C, Charnay Y. Hypocretins/orexins and narcolepsy: from molecules to disease. Rev Neurol 2003; 159 (suppl 11): 6 s35-41.
-
(2003)
Rev Neurol
, vol.159
, Issue.6 SUPPL. II
-
-
Peyron, C.1
Charnay, Y.2
-
3
-
-
7044221981
-
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients
-
Lodi R, Tonon C, Vignatelli L, et al. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients. Neurology. 63:2004;1513-1515
-
(2004)
Neurology
, vol.63
, pp. 1513-1515
-
-
Lodi, R.1
Tonon, C.2
Vignatelli, L.3
-
4
-
-
0033710848
-
Reduced number of hypocretin neurons in human narcolepsy
-
Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27:2000;469-474
-
(2000)
Neuron
, vol.27
, pp. 469-474
-
-
Thannickal, T.C.1
Moore, R.Y.2
Nienhuis, R.3
-
5
-
-
0034846670
-
Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy
-
Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 50:2001;381-388
-
(2001)
Ann Neurol
, vol.50
, pp. 381-388
-
-
Nishino, S.1
Ripley, B.2
Overeem, S.3
-
6
-
-
0035956531
-
CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
-
Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology. 57:2001;2253-2258
-
(2001)
Neurology
, vol.57
, pp. 2253-2258
-
-
Ripley, B.1
Overeem, S.2
Fujiki, N.3
-
7
-
-
0035524415
-
Immunological aspects of narcolepsy
-
Carlander B, Dauvilliers Y, Billiard M. Immunological aspects of narcolepsy. Rev Neurol. 157:(11 Pt 2):2001;S97-100
-
(2001)
Rev Neurol
, vol.157
, Issue.11 PART 2
, pp. 97-100
-
-
Carlander, B.1
Dauvilliers, Y.2
Billiard, M.3
-
8
-
-
0031830681
-
A case of multiple sclerosis with initial symptoms of narcolepsy
-
Wang CY, Kawashima H, Takami T, et al. A case of multiple sclerosis with initial symptoms of narcolepsy. No To Hattatsu. 30:1998;300-306
-
(1998)
No to Hattatsu
, vol.30
, pp. 300-306
-
-
Wang, C.Y.1
Kawashima, H.2
Takami, T.3
-
9
-
-
0346787768
-
Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult
-
Lagrange AH, Blaivas M, Gomez-Hassan D, Malow BA. Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult. Epilepsy Behav. 4:2003;788-792
-
(2003)
Epilepsy Behav
, vol.4
, pp. 788-792
-
-
Lagrange, A.H.1
Blaivas, M.2
Gomez-Hassan, D.3
Malow, B.A.4
-
10
-
-
3042792719
-
Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity
-
Boehmer LN, Wu MF, John J, Siegel JM. Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Exp Neurol. 188:2004;292-299
-
(2004)
Exp Neurol
, vol.188
, pp. 292-299
-
-
Boehmer, L.N.1
Wu, M.F.2
John, J.3
Siegel, J.M.4
-
11
-
-
4043153396
-
Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep
-
Gerashchenko D, Shiromani PJ. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Res. 1019:2004;162-169
-
(2004)
Brain Res
, vol.1019
, pp. 162-169
-
-
Gerashchenko, D.1
Shiromani, P.J.2
-
12
-
-
0033948273
-
Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome
-
Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum. 43:2000;1647-1654
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1647-1654
-
-
Waterman, S.A.1
Gordon, T.P.2
Rischmueller, M.3
-
13
-
-
1542287387
-
Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes
-
Jackson MW, Gordon TP, Waterman SA. Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology. 126:2004;819-828
-
(2004)
Gastroenterology
, vol.126
, pp. 819-828
-
-
Jackson, M.W.1
Gordon, T.P.2
Waterman, S.A.3
|